Saccà L, Orofino G, Petrone A, Vigorito C
J Clin Invest. 1984 Jun;73(6):1683-7. doi: 10.1172/JCI111375.
To identify the mechanism(s) of the altered glucoregulatory response to a glucose load in subjects with impaired glucose tolerance, we selectively quantitated the components of net splanchnic glucose balance, i.e., splanchnic glucose uptake and hepatic glucose output, as well as peripheral glucose uptake, by combining [3-3H]glucose infusion with hepatic vein catheterization. After intravenous glucose infusion (6 mg X kg-1 X min-1 for 90 min), blood glucose rose to 172 +/- 7 mg/dl in controls and 232 +/- 13 mg/dl in subjects with impaired glucose tolerance (P less than 0.01). The response of plasma insulin did not differ significantly between the two groups (29 +/- 4 vs. 40 +/- 10 microU/ml at 90 min in control and in glucose intolerant subjects, respectively; P = NS). In both groups, glucose infusion caused the net splanchnic glucose balance to switch from the net output of the basal state to a net glucose uptake. However, this effect was more marked in subjects with impaired glucose tolerance than in control subjects (at 90 min: 2.83 +/- 0.53 vs. 1.60 +/- 0.18 mg X kg-1 X min-1, respectively: P less than 0.05). The different pattern of splanchnic glucose balance was entirely accounted for by a greater rise in splanchnic glucose uptake in the group of glucose intolerants , as the suppression of endogenous glucose output by the glucose load was practically complete in both groups. In contrast, glucose uptake by peripheral tissues increased considerably less in subjects with impaired glucose tolerance than in controls (2.2-2.6 vs 3.6-4.1 mg X kg-1 X min-1, respectively, between 60 and 90 min; P less than 0.01-0.001). Furthermore, a net splanchnic lactate uptake was present in the basal state, which was inhibited by the glucose load and switched to a comparable net lactate output in both groups. These results indicate that the mechanism responsible for the altered glucoregulation in subjects with impaired glucose tolerance resides entirely in the peripheral tissues whose ability to dispose of a glucose load is drastically reduced. On the other hand, no defect is detectable in any of the explored mechanisms regulating splanchnic glucose metabolism during the disposal of an exogenous glucose load.
为了确定糖耐量受损患者对葡萄糖负荷的糖调节反应改变的机制,我们通过将[3-3H]葡萄糖输注与肝静脉插管相结合,选择性地定量了内脏葡萄糖净平衡的组成部分,即内脏葡萄糖摄取和肝葡萄糖输出,以及外周葡萄糖摄取。静脉输注葡萄糖(6mg·kg-1·min-1,持续90分钟)后,对照组血糖升至172±7mg/dl,糖耐量受损患者血糖升至232±13mg/dl(P<0.01)。两组间血浆胰岛素反应无显著差异(对照组和糖耐量受损患者在90分钟时分别为29±4和40±10μU/ml;P=无显著性差异)。在两组中,葡萄糖输注均导致内脏葡萄糖净平衡从基础状态的净输出转变为净葡萄糖摄取。然而,这种效应在糖耐量受损患者中比在对照组中更明显(90分钟时:分别为2.83±0.53和1.60±0.18mg·kg-1·min-1;P<0.05)。糖耐量受损组内脏葡萄糖摄取的更大升高完全解释了内脏葡萄糖平衡的不同模式,因为葡萄糖负荷对内源性葡萄糖输出的抑制在两组中实际上是完全的。相反,糖耐量受损患者外周组织的葡萄糖摄取增加明显少于对照组(60至90分钟之间分别为2.2-2.6和3.6-4.1mg·kg-1·min-1;P<0.01-0.001)。此外,基础状态下存在内脏乳酸净摄取,葡萄糖负荷可抑制该摄取,并在两组中转变为相当的乳酸净输出。这些结果表明,糖耐量受损患者糖调节改变的机制完全存在于外周组织中,其处理葡萄糖负荷的能力大幅降低。另一方面,在处理外源性葡萄糖负荷期间,调节内脏葡萄糖代谢的任何探索机制均未检测到缺陷。